Paper22746331
Pseudomonas aeruginosa twitching motility: type IV pili in action.
Burrows LL. Annu Rev Microbiol, 2012. Cited by 514 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pseudomonas aeruginosa twitching motility: type IV pili in action. Papers, record 22746331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22746331
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fimbriae, Bacterial | Major topic |
| Locomotion | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Protein Transport |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Canadian Institutes of Health Research | Canada | PubMed |
Source PubMed
Cited by377
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 514 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,949,064 | Bacterial Surfaces and Barriers: Biogenesis and Pathogen-Host Interactions. | Chem Rev | 2026 | https://conductscience.org/library/papers/42949064 | PubMed |
| 42,943,234 | Multi-Target Virtual Screening of Natural Products Against Virulence-Associated Proteins of Pseudomonas aeruginosa PAO1 for Antivirulence Candidate Prioritization. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42943234 | PubMed |
| 42,921,315 | Phenazine Biosynthesis Inhibitors as Pseudomonas aeruginosa Antivirulence Agents. | ACS Bio Med Chem Au | 2026 | https://conductscience.org/library/papers/42921315 | PubMed |
| 42,897,133 | Characterization of hypothetical proteins reveals function modules and virulence factors in Pseudomonas aeruginosa. | Nat Commun | 2026 | https://conductscience.org/library/papers/42897133 | PubMed |
| 42,818,388 | Orthogonal microfluidic approaches reveal force-enhanced migration of bacterial populations on surfaces. | bioRxiv | 2026 | https://conductscience.org/library/papers/42818388 | PubMed |
| 42,747,195 | Pathogen local adaptation shapes Pierce's disease of grapevines outcomes under field conditions. | Appl Environ Microbiol | 2026 | https://conductscience.org/library/papers/42747195 | PubMed |
| 42,717,253 | Microbial adhesion promotes Piezo1 activation to initiate innate immunity. | Nat Immunol | 2026 | https://conductscience.org/library/papers/42717253 | PubMed |
| 42,423,835 | Host-pathogen interactions during ESKAPE-mediated urinary tract infections and ventilator-associated pneumonia: a review. | Folia Microbiol (Praha) | 2026 | https://conductscience.org/library/papers/42423835 | PubMed |
| 42,346,555 | Diverse Bacterial Properties Influence Dispersal Along Fungal Networks. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42346555 | PubMed |
| 42,287,141 | To Move or Not to Move: When and How Bacteria Suppress Flagellar Motility. | Mol Microbiol | 2026 | https://conductscience.org/library/papers/42287141 | PubMed |
| 42,215,499 | Secretin-interacting plug proteins prevent antibiotic influx during type IV pilus assembly in Pseudomonas aeruginosa. | Nat Commun | 2026 | https://conductscience.org/library/papers/42215499 | PubMed |
| 42,207,290 | Phage-derived proteins and conjugates induce pilus detachment. | J Bacteriol | 2026 | https://conductscience.org/library/papers/42207290 | PubMed |
| 42,206,754 | Isolation of a Novel Lytic Pseudomonas aeruginosa Phage Henu5 and Fitness Costs of Phage-Driven Resistance. | Microb Biotechnol | 2026 | https://conductscience.org/library/papers/42206754 | PubMed |
| 42,012,866 | The Omp85 family protein, TamA, exhibits characteristics of a suitable drug target against Pseudomonas aeruginosa. | Microbiology (Reading) | 2026 | https://conductscience.org/library/papers/42012866 | PubMed |
| 41,989,932 | Exploring the Diversity and Function of the SPFH-Domain Containing Proteins in Pseudomonas aeruginosa. | Environ Microbiol Rep | 2026 | https://conductscience.org/library/papers/41989932 | PubMed |
| 41,951,944 | Role of cell-associated and secretion-independent virulence factors of Pseudomonas aeruginosa in microbial keratitis and anti-virulence therapeutic strategies. | Eur J Clin Microbiol Infect Dis | 2026 | https://conductscience.org/library/papers/41951944 | PubMed |
| 41,910,255 | The repertoire of resistance mutations selected by a Pseudomonas aeruginosa type IV pilus-targeting lytic bacteriophage. | mBio | 2026 | https://conductscience.org/library/papers/41910255 | PubMed |
| 41,900,458 | Phenotypic and Metabolic Variations in High-Risk Clones of Multidrug-Resistant Pseudomonas aeruginosa. | Microorganisms | 2026 | https://conductscience.org/library/papers/41900458 | PubMed |
| 41,660,827 | Defining the role of Pseudomonas aeruginosa PilY1 in signaling and virulence. | J Bacteriol | 2026 | https://conductscience.org/library/papers/41660827 | PubMed |
| 41,625,360 | Pre-adsorption of serum albumin on biomaterial surfaces modulates bacteria-surface interactions and alters bacterial physiological responses. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41625360 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22746331
GET https://conductscience.org/api/papers/v1/22746331/cited_by?page=2